Infermedica

Infermedica is a leading global digital health company founded in 2012, specializing in AI-powered solutions for symptom analysis and patient triage. Their Medical Guidance Platform leverages an inference engine, a vast medical knowledge base developed with over 77,000 physician hours, and natural language processing to provide medical guidance. The platform boasts a 95% engine-accuracy rate, supports over 100 healthcare providers and insurers in 35 countries and 24 languages, and has performed over 23 million health checkups. They offer B2B solutions like Symptom Checker, Triage tool, and Intake API, alongside a B2C app, Symptomate. Infermedica is HIPAA-compliant, ISO certified, and has raised a total of $45 million in funding, including a $30 million Series B in January 2022.